Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia

Obstetrics and Gynecology

Volumn 107, Issue 4, 2006, Pages 896-900

  Oron, Galia ^a   Ben Haroush, Avi ^b   Hod, Moshe ^b   Orvieto, Raoul ^b   Bar, Jacob ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; ESTRADIOL; MEMBRANE PROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; BLOOD; COMPARATIVE STUDY; CYTOLOGY; GESTATIONAL AGE; HOSPITALIZATION; MATERNAL AGE; METABOLISM; PARITY; PHYSIOLOGY; PREGNANCY OUTCOME; PROBABILITY; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD40 LIGAND; ENDOTHELIAL CELLS; FEMALE; GESTATIONAL AGE; HUMANS; MATERNAL AGE; PARITY; PLATELET ACTIVATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33646084609     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000206206.99212.9e     Document Type: Article

References (28)

1. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992;357:80-2.
2. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992;11:4313-21.
3. Grewal IS, Flavell RA. The CD40 ligand: at the center of the immune universe? Immunol Res 1997;16:59-70.
4. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forser R, Muller-Berghaus G, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-4.
5. Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, et al. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 1995;182:1857-64.
6. Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001;98:1047-54.
7. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003;92;1041-8.
8. Holthe MR, Staff AC, Berge LN, Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynecol 2004;190:1128-34.
9. Douglas JT, Shah M, Lowe GD, Belch JJ, Forbes CD, Prentice CR. Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemost 1982;47:54-5.
10. Bar J, Bardin R, Chen R, Pardo J, Hod M, Peled Y, et al. Surface expression of neutrophil adhesion molecules in pregnant women at risk for hypertensive complications. Hypertens Pregnancy 2003;22:165-72.
11. Janes SL, Kyle PM, Redman C, Goodall AH. Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thromb Haemost 1995;74:1059-63.
12. Konijnenberg A, van der Post JA, Mol BW, Schaap MC, Lazarov R, Bleker OP, et al. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study. Am J Obstet Gynecol 1997;177:434-42.
13. Roberts JM, Pearson GD, Cutler JA, Lindheimer MD. Summary of the NHLBI Working Group in Research on Hypertension During Pregnancy. Hypertens Pregnancy 2003;22:109-27.
14. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF, et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004;173:2227-30.
15. Nakano Y, Oshima T, Matsuura H, Kajiyama G, Kambe M. Effect of 17beta-E2 on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis. Arterioscler Thromb Vasc Biol 1998;18:961-7.
16. Zeisler H, Jirecek S, Hohlagschwandtner M, Knofler M, Tempfer C, Livingston JC. Concentrations of estrogens in patients with preeclampsia. Wien Klin Wochenschr 2002;114:458-61.
17. Troisi R, Potischman N, Roberts JM, Ness R, Crombleholme W, Lykins D, et al. Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 2003;32:455-60.
18. Bar J, Zosmer A, Hod M, Elder MG, Sullivan MH. The regulation of platelet aggregation in vitro by interleukin-1beta and tumor necrosis factor-alpha: changes in pregnancy and in pre-eclampsia. Thromb Haemost 1997;78:1255-61.
19. Mellembakken JR, Solum NO, Ueland T, Videm V, Aukrust P. Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia: possible role of platelet activation. Thromb Haemost 2001;86:1272-6.
20. Bar J, Ben-Haroush A, Lahav J, Sullivan M. Interaction between platelets and cytokines - a possible role in the pathogenesis of preeclampsia. Vasc Dis Prev 2004;1:101-7.
21. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
22. Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes. Heart 2002;87:201-4.
23. Yaguchi A, Lobo FL, Vincent JL, Pradier O. Platelet function in sepsis. J Thromb Haemost 2004;2:2096-102.
24. Spivak JL, Barosi G, Tognoni G, Barbui T, Finazzi G, Marchioli R, et al. Chronic myeloproliferative disorders. Hematology 2003;2003:200-24.
25. Orvieto R. Controlled ovarian hyperstimulation: an inflammatory state. J Soc Gynecol Investig 2004;11:424-6.
26. Caulin-Glaser T, Watson CA, Pardi R, Bender JR. Effects of 17beta-E2 on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 1996;98:36-42.
27. Bar J, Lahav J, Hod M, Ben-Rafael Z, Weinberger I, Brosens J. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-E2 and medroxyprogesterone acetate in postmenopausal women. Thromb Haemost 2000;84:695-700.
28. Jayachandran M, Miller VM. Human platelets contain estrogen receptor alpha, caveolin-1 and estrogen receptor associated proteins. Platelets 2003;14:75-81.